A New Syndrome: Isotretinoin (Accutane) Malformation

Roche Laboratory division of Hoffmann-La Roche, Inc. Package insert information issued March, 1984.

Accutane (Isotretinoin/Roche) capsules, physician information Hoffman-La Roche Inc., 1984.

Food and Drug Administration Drug Bulletin, Department of Health and Human Services, Aug. 1984, Vol. 14, Number 2, pages 15–16.

Public Health Service Food and Drug Administration, FDA Drug Bulletin, 1984, Vol. 14, Number 2, page 16.

Hill M Reba MD : Focus, Medical News Letter of Texas Children Hospital, Houston, Texas, Vol. 2 Number 3, 1984.

Braun T John : Isotretinoin dysmorphic syndrome. Lancet 1:506–507, 1984.

Rosa F : Teratogenecity of isotretinoin. Lancet 2:513, 1983.

Newly recognized human teratogen. MMWR 33:171–173, 1984.

Fantel AG Shepard TH Newell-Morris LL Moffett BC : Teratogenic effects of retinoic acid in monkeys. General Features Teratol 15:65–71, 1977.

Peck GL Olsen TG Yoder FW Strauss JS Downing DT : Remissions of cystic and conglobate acne with 13-cis-retinoin acid. N Engl J Med 300:329–333, 1979.

Katz RA Jorgensen J Nigra TP : Elevation of serum triglycerides levels from all isotretinoin in disorders of keratinization. Arch Dermatol 116:1369–1372, 1980.